OMG. You need to brush up on your bs skills.
ODAC is the Oncology Drugs Advisory Committee. ODAC did not raise issues regarding potency, consistency, etc. FDA raised these issues in a briefing document prepared for ODAC. They asked ODAC to discuss these issues... but not to vote on them. FDA made a presentation about these issues and MSB gave their response. ODAC basic response to all of this?
Why the heck are you asking us to discuss these issues? This isn't our area of expertise.
Meanwhile, on the efficacy issue, ODAC voted overwhelmingly in favor.
But tell me again how ODAC voted to approve despite issues they raised regarding potency and cosistency. And tell me again how you are aware of what "went down."
MSB Trading 2021 - paradigm shift, page-7843
-
- There are more pages in this discussion • 2,368 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 96.8¢ | 93.5¢ | $4.207M | 4.417M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 42268 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 48002 | 3 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |